ProCE Banner Activity

How to Apologize for Misgendering a Transgender Patient

Video

Watch this HCP‒patient interaction video capturing the do’s and don’t’s for apologizing after misgendering a transgender patient.

Released: April 07, 2023

Share

Faculty

Yee Won Chong

Yee Won Chong, BA

Co-filmmaker, Trans Dudes with Lady Cancer
Senior Fellow, Racial Equity
Western States Center
Equity, Diversity, and Inclusion Strategist and Consultant
Portland, Oregon

Madeline B. Deutsch

Madeline B. Deutsch, MD, MPH

Professor of Clinical Family & Community Medicine
Medical Director, Gender Affirming Health Program
Department of Family & Community Medicine
University of California San Francisco
San Francisco, California

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

Merck Sharp & Dohme Corp.

Target Audience

This educational program is intended for all healthcare professionals across multiple disciplines and specialties who care for transgender individuals, including medical oncologists, gynecologists, HIV specialists, primary care physicians, pharmacists, nurses, nurse practitioners, and physician assistants.

Program Learning Goal

The goal of this education is to advance knowledge, competence, and performance of healthcare professionals to ensure they are providing inclusive care for all patients, including cancer screening and preventive care for transgender individuals.

Disclosure

Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:

Primary Author

Yee Won Chong, BA

Co-filmmaker, Trans Dudes with Lady Cancer
Senior Fellow, Racial Equity
Western States Center
Equity, Diversity, and Inclusion Strategist and Consultant
Portland, Oregon

Yee Won Chong: other financial or material support: GlaxoSmithKline, Takeda.

Madeline B. Deutsch, MD, MPH

Professor of Clinical Family & Community Medicine
Medical Director, Gender Affirming Health Program
Department of Family & Community Medicine
University of California San Francisco
San Francisco, California

Madeline B. Deutsch, MD, MPH, has no relevant financial relationships to disclose.

The planners and content peer reviewers from Clinical Care Options, LLC do not have any relevant financial relationships to disclose.

Format

This program has been made available online.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.